Lanean...
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension
Rationale: Although amphetamines are recognized as “likely” agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described. Objectives: To prospectively characterize the clinical presentation, histopathology,...
Gorde:
| Argitaratua izan da: | Am J Respir Crit Care Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Thoracic Society
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5855067/ https://ncbi.nlm.nih.gov/pubmed/28934596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201705-0943OC |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|